TGM2 and Hepatic fibrosis: Targeted TG2 therapies in the treatment of celiac disease and liver fibrosis have recently been progressed to Phase 2b clinical trials [22,23]; however, there remains a need to further investigate the roles of TG2 in other biological contexts.